NEWS

Upcoming Winter Short Course: Mathematical Modelling of Infectious Diseases

Australian Institute of Tropical Health and Medicine, JCU, is holding a one-week Mathematical Modelling and Programming course [July 19-23]

2021 Seed Funding Awardees Announced

Congratulations to the recipients of our TB-CRE small project Seed Funding Award for the March 2021 round! The TB-CRE supports...

NHMRC's 10 of the Best: Professor Ben Marais

The TB-CRE's own Professor Ben Marais has been featured in the current NHMRC "Ten of the Best"!

Acting today to address the challenges of tomorrow

White paper: A vision for WHO work with Member States and partners in the Western Pacific.

Tuberculosis and widespread public acceptance of face masks after COVID-19

Lancet Respir Med article: "Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?"

Quick and safe vax method

Fantastic article from The Australian on our recent work developing a new method for rapid synthesis of safe vaccines.

New method to assist fast-tracking of vaccines for pre-clinical tests

Novel tuberculosis vaccine demonstrated strong immune response in mice - MEDIA RELEASE - Scientists in Australia have developed a method...

Roadmaps and picking a lane: Time for a clear national COVID-19 strategy

In a Letter to the Editor published today in the Medical Journal of Australia, the TB-CRE's modelling group reflects on Australia's...

Read our favourite Child TB articles

Our selection of interesting and relevant Child TB articles from the November 2020 Paediatric Respiratory Reviews tuberculosis...

The latest national TB notification report for Australia, (2015-2018)

Authors, including the TB-CRE investigators Justin Denholm and Chris Coulter, present and analyse TB and MDR-TB data from the National...

Ethics and Multidrug Resistant Latent TB

Should preventative therapy be given to patients with latent multidrug resistant TB? Authors Binh Nguyen, Greg Fox, Paul Mason, and...

PERISKOPE-TB developed in collaboration with TB-CRE investigators

Discovery and validation of personalised risk predictor for incident TB. [Written by Gupta et al. Nature Medicine]